Mezzion Pharma receives clear FDA path forward for the approval of Udenafil for single ventricle heart disease

Novavax initiates phase 3 trial of its COVID-19 omicron booster

Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19

Next-gen immunotherapy drug shows promise in several advanced-stage cancers

Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs

Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries

Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap

Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool

The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs

Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device

Objective tracking data combined with cohort data to drive medicine of the future

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear

Dapagliflozin met primary endpoint in DELIVER Phase III trial

Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction

Micro-Tech Endoscopy partners with Wision A.I. to distribute polyp detection software in the U.S.

The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures